转移性结直肠癌经化疗和(或)靶向标准治疗后,维持治疗已成为临床广泛应用的治疗方案,并展现出较好的临床疗效,已成为临床研究热点。当前化疗药物、靶向药物、化疗药物联合靶向药物等临床研究相继大量开展。文章对转移性结直肠癌维持治疗临床进展进行综述,在此基础上,对存在的问题进行分析与展望。 After the treatment of metastatic colorectal cancer by chemotherapy and / or targeted standard therapy, maintenance therapy has become a widely used clinical treatment program and has shown good clinical efficacy. It has become a hot research topic in clinical research. Current clinical trials of chemotherapeutics, targeted drugs, chemotherapeutic drugs and targeted drugs have been carried out in large quantities one after another. The article reviews the clinical progress of metastatic colorectal cancer maintenance therapy, and on this basis, analyzes and prospects the existing problems.